| SW |
Report |
Adjusted EBITDA |
BEAT |
pred ~$1.19B vs. cons $1.15B |
MEDIUM |
| SW |
Report |
North America adjusted EBITDA |
BEAT |
pred ~$665M vs. cons $650M |
MEDIUM |
| SW |
Report |
Net sales |
IN-LINE |
pred ~$7.96B vs. cons $7.91B |
MEDIUM |
| SW |
Guide |
Q3 adjusted EBITDA guidance |
LOWER |
guide ~$1.36B vs. cons $1.42B (2026Q3) |
MEDIUM |
| SW |
Guide |
Full-year adjusted EBITDA guidance |
UNCHANGED |
guide ~$5.15B midpoint vs. cons $5.18B (FY2026) |
MEDIUM |
| SW |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.7% |
— |
MEDIUM |
| SW |
Return |
5-day cumulative residual |
-4.1% (FOLLOW-THROUGH) |
The Q2 EBITDA beat of ~$1.19B vs. $1.15B is outweighed by Q3 guidance of ~$1.36B vs. $1.42B; the implied heavier Q4 ramp and elevated energy, freight and fiber costs drive negative out-period estimate revisions. |
MEDIUM |